Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury

Intrathecal baclofen (ITB) has been known to reduce spasticity which did not respond to oral medications and botulinum toxin treatment. However, few results have been reported comparing the effects of ITB therapy in patients with cerebral palsy (CP) and acquired brain injury. This study aimed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Young Kwon, Lee, Kil Chan, Cho, Han Eol, Chae, Minji, Chang, Jin Woo, Chang, Won Seok, Cho, Sung-Rae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571990/
https://www.ncbi.nlm.nih.gov/pubmed/28834868
http://dx.doi.org/10.1097/MD.0000000000007472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571990/
https://www.ncbi.nlm.nih.gov/pubmed/28834868
http://dx.doi.org/10.1097/MD.0000000000007472

Ejemplares similares